Gam Holding Ag Sarepta Therapeutics, Inc. Transaction History

Gam Holding Ag

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$69.38 - $86.75 $69 - $86	-1 Reduced 0.01%	7,186 $559,000
Q1 2021 May 10, 2021	BUY	$72.25 - $168.95 $519,260 - $1.21 Million	7,187 New	7,187 $536,000
Q4 2020 Feb 10, 2021	SELL	$125.56 - $178.74 $4.13 Million - $5.89 Million	-32,931 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$127.12 - $172.34 $635 - $861	5 Added 0.02%	32,931 $4.62 Million
Q2 2020 Aug 10, 2020	SELL	$93.0 - $171.7 $577,158 - $1.07 Million	-6,206 Reduced 15.86%	32,926 $5.28 Million
Q1 2020 May 12, 2020	BUY	$82.38 - $131.64 $247 - $394	3 Added 0.01%	39,132 $3.83 Million
Q4 2019 Feb 06, 2020	BUY	$76.53 - $135.58 $229 - $406	3 Added 0.01%	39,129 $5.05 Million
Q1 2019 May 10, 2019	BUY	$106.67 - $151.68 $2.63 Million - $3.74 Million	24,626 Added 169.83%	39,126 $4.66 Million
Q4 2018 Feb 08, 2019	BUY	$97.32 - $148.76 $1.41 Million - $2.16 Million	14,500 New	14,500 $1.58 Million
Q2 2018 Aug 09, 2018	SELL	$71.74 - $153.69 $1.66 Million - $3.57 Million	-23,200 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $1.11 Million - $1.32 Million	23,200	23,200 $1.29 Million

529

84.1M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

Stay updated on Gam Holding Ag with notifications on news.